Research information (NIH) | SARS-CoV-2 data (NCBI)
`
`| Prevention and treatment information (HHS) | Espanol
`
`National Center for BiotechnologyInformation
`
`NIH) National Library of Medicine
`
`
`
` Publ{Med.Zov “Cardiovascular Diseases” AND “Cardiovascular System" AND “cardiology” a
`
`
`
`
`
`Advanced Create alert Create RSS
`
`User Guide
`
`Sorted by: Best match
`
`Display options TF
`
`95? results
`
`Page
`
`1
`
`of 26 5 >
`
`3
`es
`7 article found by citation matching
`
`Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by
`Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical
`Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC),
`Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish
`Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH)
`;
`Cardiovascular System Study Group.
`Simgek-Yavuz5, et al. Turk Gogus Kalp Damar Cerrahisi Derg. 2020. PMID: 32175140 Free PMC article.
`
`[_] Angiotensin Il cell signaling: physiological and pathological effects in the
`1
`cardiovascular system.
`Cite Mehta PK, Griendling KK.
`Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97. doi: 10.1152/ajpcell.00287.2006. Epub 2006 Jul 26.
`Share
`:
`Review,
`
`PMID: 16870827
`
`Free article.
`
`aeRe
`T
`a
`My NCBI FILTERS [4
`
`RESULTS BY YEAR
`7
`
`i
`
`eeazuma
`
`1958
`
`2006
`
`TEXT AVAILABILITY
`
`[_] Abstract
`[_] Free full text
`Oo Full text
`u
`&
`
`ARTICLE ATTRIBUTE
`
`The renin-angiotensin system is a central component of the physiological and pathological responses of
`||Associated data
`cardiovascular system. ...This review focuses on the structure and function of AT(1) receptors and the
`
`ARTICLE TYPE
`
`[_] Books and Documents
`1 Clinical Trial
`
`major signaling mechanisms by which angictensin influ...
`
`Liquidia's Exhibit 1117
`|] Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic
`Page 1
`2
`and pleiotropic effects.
`
`Liquidia's Exhibit 1117
`Page 1
`
`

`

`COVID-19 Information
`Public health information (CDC)
`Research information (NIH)
`SARS-CoV-2 data (NCBI)
`Prevention and treatment information (HHS)
`Español
`
` 
`
`252 results
`
`
`
`Page 1 of
`26
`
`1 article found by citation matching
`Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular
`Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology
`(TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and
`Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group.
`PMID: 32175140 Free PMC article.
`
`1 Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
`Mehta PK, Griendling KK.
`Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97. doi: 10.1152/ajpcell.00287.2006. Epub 2006 Jul 26.
`PMID: 16870827 Free article. Review.
`
`2 Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects.
`Manolis AS, Tzeis S, Triantafyllou K, Michaelidis J, Pyrros I, Sakellaris N, Kranidis A, Melita H.
`Curr Drug Targets Cardiovasc Haematol Disord. 2005 Oct;5(5):355-75. doi: 10.2174/156800605774370326.
`PMID: 16248829 Review.
`
`3 Thyrotoxicosis and the cardiovascular system.
`Roffi M, Cattaneo F, Brandle M.
`Minerva Endocrinol. 2005 Jun;30(2):47-58.
`PMID: 15988401 Review.
`
`4 Endothelin receptor antagonists and cardiovascular diseases of aging.
`Love MP, McMurray JJ.
`Drugs Aging. 2001;18(6):425-40. doi: 10.2165/00002512-200118060-00005.
`PMID: 11419917 Review.
`
`5 Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
`Ouyang P, Michos ED, Karas RH.
`J Am Coll Cardiol. 2006 May 2;47(9):1741-53. doi: 10.1016/j.jacc.2005.10.076. Epub 2006 Apr 17.
`PMID: 16682298 Free article. Review.
`
`6 Thyrotoxicosis and the cardiovascular system: subtle but serious effects.
`Roffi M, Cattaneo F, Topol EJ.
`Cleve Clin J Med. 2003 Jan;70(1):57-63. doi: 10.3949/ccjm.70.1.57.
`PMID: 12549727 Free article. Review.
`
`7 Transforming growth factor beta and cardiovascular diseases: the other facet of the 'protective cytokine'.
`Dabek J, Kułach A, Monastyrska-Cup B, Gasior Z.
`Pharmacol Rep. 2006 Nov-Dec;58(6):799-805.
`
`Liquidia's Exhibit 1117
`Page 2
`
`

`

`PMID: 17220537 Free article. Review.
`
`8 Hormones of the Cardiovascular System.
`Hall ME, Yanes L, Long RC, Koch CA.
`2015 Feb 6. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P,
`Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA,
`Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
`PMID: 25905321 Free Books & Documents. Review.
`
`9
`
`[Diabetes mellitus in cardiology practice in Spain. Survey by the Working Group on Heart and Diabetes regarding the
`importance of diabetes mellitus in relation with other cardiovascular diseases].
`Palma Gámiz JL, Hernández Madrid A, Bertomeu Martínez V, González-Juanatey JR, López García-Aranda V, Calderón Montero A, Alegría Ezquerra E, Cadierno
`Carpintero M; Grupo de Trabajo de Corazón y Diabetes de la Sociedad Española de Cardiología.
`Rev Esp Cardiol. 2004 Jul;57(7):661-6.
`PMID: 15274851 Free article. Spanish.
`
`10 Depression, anxiety, and the cardiovascular system: the cardiologist's perspective.
`Sheps DS, Sheffield D.
`J Clin Psychiatry. 2001;62 Suppl 8:12-6; discussion 17-8.
`PMID: 12108816 Review.
`
`Page 2
`11 The protective effects of estrogen on the cardiovascular system.
`Mendelsohn ME, Karas RH.
`N Engl J Med. 1999 Jun 10;340(23):1801-11. doi: 10.1056/NEJM199906103402306.
`PMID: 10362825 Review. No abstract available.
`
`12 Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
`Noll G, Wenzel RR, Binggeli C, Corti C, Lüscher TF.
`Eur Heart J. 1998 Jun;19 Suppl F:F32-8.
`PMID: 9651733 Review.
`
`13 Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.
`Berry CE, Hare JM.
`J Physiol. 2004 Mar 16;555(Pt 3):589-606. doi: 10.1113/jphysiol.2003.055913. Epub 2003 Dec 23.
`PMID: 14694147 Free PMC article. Review.
`
`14 Tetrahydrobiopterin and cardiovascular disease.
`Moens AL, Kass DA.
`Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2439-44. doi: 10.1161/01.ATV.0000243924.00970.cb. Epub 2006 Aug 31.
`PMID: 16946131 Review.
`
`15 Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
`Pasquale PD, Stefano GD, Paterna S.
`Ital Heart J. 2000 Sep;1(9):595-604.
`PMID: 11130838 Review.
`
`16 Cardiology and AIDS--HAART and the consequences.
`Hoffmann C, Jaeger H.
`Ann N Y Acad Sci. 2001 Nov;946:130-44. doi: 10.1111/j.1749-6632.2001.tb03908.x.
`PMID: 11762982 Review.
`
`17 Human gene therapy and imaging: cardiology.
`Wu JC, Yla-Herttuala S.
`Eur J Nucl Med Mol Imaging. 2005 Dec;32 Suppl 2:S346-57. doi: 10.1007/s00259-005-1897-6.
`
`Liquidia's Exhibit 1117
`Page 3
`
`

`

`PMID: 16096829 Review.
`
`18 Cardiovascular physiology-changes with aging.
`Cheitlin MD.
`Am J Geriatr Cardiol. 2003 Jan-Feb;12(1):9-13. doi: 10.1111/j.1076-7460.2003.01751.x.
`PMID: 12502909 Review.
`
`19 Adiponectin actions in the cardiovascular system.
`Hopkins TA, Ouchi N, Shibata R, Walsh K.
`Cardiovasc Res. 2007 Apr 1;74(1):11-8. doi: 10.1016/j.cardiores.2006.10.009. Epub 2006 Oct 20.
`PMID: 17140553 Free PMC article. Review.
`
`20 Depression and cardiovascular disease: mechanisms of interaction.
`Joynt KE, Whellan DJ, O'Connor CM.
`Biol Psychiatry. 2003 Aug 1;54(3):248-61. doi: 10.1016/s0006-3223(03)00568-7.
`PMID: 12893101 Review.
`
`Page 3
`21 Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
`Yosefy C.
`Acta Diabetol. 2003 Dec;40 Suppl 2:S380-8. doi: 10.1007/s00592-003-0124-9.
`PMID: 14704873 Review.
`
`22 The controversy over advanced cardiovascular imaging: relative roles of radiologists, cardiologists, and other physicians
`in CT and MRI of the cardiovascular system.
`Levin DC, Rao VM, Frangos AJ, Parker L, Sunshine JH.
`J Am Coll Radiol. 2006 Jan;3(1):16-8. doi: 10.1016/j.jacr.2005.09.014.
`PMID: 17412000
`
`23 Cardiovascular disease in athletes.
`Vasamreddy CR, Ahmed D, Gluckman TJ, Blumenthal RS.
`Clin Sports Med. 2004 Jul;23(3):455-71, x. doi: 10.1016/j.csm.2004.02.002.
`PMID: 15262382 Review.
`
`24 Extracellular matrix and cardiovascular diseases.
`Ju H, Dixon IM.
`Can J Cardiol. 1996 Dec;12(12):1259-67.
`PMID: 8987966 Review.
`
`25 Physical activity and cardiovascular health. NIH Consensus Development Panel on Physical Activity and Cardiovascular
`Health.
`[No authors listed]
`JAMA. 1996 Jul 17;276(3):241-6.
`PMID: 8667571 Review.
`
`26
`
`Interfaces of psychopharmacology and cardiology--part one.
`Risch SC, Groom GP, Janowsky DS.
`J Clin Psychiatry. 1981 Jan;42(1):23-34.
`PMID: 6109716 Review.
`
`27 The DD-ACE genotype and cardiovascular disease.
`Butler R.
`Pharmacogenomics. 2000 May;1(2):153-67. doi: 10.1517/14622416.1.2.153.
`PMID: 11256587 Review.
`
`Liquidia's Exhibit 1117
`Page 4
`
`

`

`28 Proteomics: state of the art and its application in cardiovascular research.
`Scobioala S, Klocke R, Michel G, Kuhlmann M, Nikol S.
`Curr Med Chem. 2004 Dec;11(24):3203-18. doi: 10.2174/0929867043363767.
`PMID: 15579008 Review.
`
`29 Cardiovascular effects of air pollution: what to measure in ECG?
`Zareba W, Nomura A, Couderc JP.
`Environ Health Perspect. 2001 Aug;109 Suppl 4(Suppl 4):533-8. doi: 10.1289/ehp.01109s4533.
`PMID: 11544159 Free PMC article. Review.
`
`30
`
`[Evaluation of the effects of occupational noxae on the cardiovascular system].
`Muzi G, Locati EH, Murgia N, Ambrosio G, Abbritti G.
`Med Lav. 2004 Mar-Apr;95(2):145-57.
`PMID: 15218747 Review. Italian.
`
`31 Nitric oxide and oxidative stress in cardiovascular aging.
`Raju SV, Barouch LA, Hare JM.
`Sci Aging Knowledge Environ. 2005 May 25;2005(21):re4. doi: 10.1126/sageke.2005.21.re4.
`PMID: 15917507 Review.
`
`Page 4
`
`32 Cardiovascular complications of cocaine.
`Om A.
`Am J Med Sci. 1992 May;303(5):333-9. doi: 10.1097/00000441-199205000-00014.
`PMID: 1533749 Review.
`
`33 Congenital defects of the cardiovascular system of dogs: studies in comparative cardiology.
`Patterson DF.
`Adv Vet Sci Comp Med. 1976;20:1-37.
`PMID: 795284 Review. No abstract available.
`
`34 Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the
`American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of
`Cardiology Foundation.
`Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH; American Heart Association Council on Nutrition, Physical Activity, and Metabolism.
`Circulation. 2004 Nov 2;110(18):2952-67. doi: 10.1161/01.CIR.0000145546.97738.1E. Epub 2004 Oct 27.
`PMID: 15509809
`
`35 Cardiotoxicity induced by chemotherapy and antibody therapy.
`Yeh ET.
`Annu Rev Med. 2006;57:485-98. doi: 10.1146/annurev.med.57.121304.131240.
`PMID: 16409162 Review.
`
`36 Cardiovascular effects of cocaine abuse.
`Das G.
`Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):521-8.
`PMID: 8294163 Review.
`
`37 Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for
`cardiovascular disease.
`Zieman SJ, Kass DA.
`Drugs. 2004;64(5):459-70. doi: 10.2165/00003495-200464050-00001.
`PMID: 14977384 Review.
`
`38 Alcohol and the heart. The long-term effects of alcohol on the cardiovascular system.
`
`Liquidia's Exhibit 1117
`Page 5
`
`

`

`Moushmoush B, Abi-Mansour P.
`Arch Intern Med. 1991 Jan;151(1):36-42. doi: 10.1001/archinte.151.1.36.
`PMID: 1985607 Review. No abstract available.
`
`39 L-arginine in cardiovascular disease: dream or reality?
`Tousoulis D, Antoniades C, Tentolouris C, Goumas G, Stefanadis C, Toutouzas P.
`Vasc Med. 2002 Aug;7(3):203-11. doi: 10.1191/1358863x02vm434ra.
`PMID: 12553744 Review.
`
`40 Obesity--a critical issue in preventive cardiology: the Bogalusa Heart Study.
`Berenson GS.
`Prev Cardiol. 2005 Fall;8(4):234-41; quiz 242-3. doi: 10.1111/j.0197-3118.2005.04485.x.
`PMID: 16230878 Free article. Review.
`
`Page 5
`41 Thyroid disease and its treatment: short-term and long-term cardiovascular consequences.
`Osman F, Gammage MD, Franklyn JA.
`Curr Opin Pharmacol. 2001 Dec;1(6):626-31. doi: 10.1016/s1471-4892(01)00107-2.
`PMID: 11757819 Review.
`
`42 Trends in genomic analysis of the cardiovascular system.
`Moldovan L, Moldovan NI.
`Arch Pathol Lab Med. 2002 Mar;126(3):310-6. doi: 10.5858/2002-126-0310-TIGAOT.
`PMID: 11860305 Review.
`
`43 Molecular biology of angiotensin receptors and their role in human cardiovascular disease.
`Regitz-Zagrosek V, Neuss M, Holzmeister J, Warnecke C, Fleck E.
`J Mol Med (Berl). 1996 May;74(5):233-51. doi: 10.1007/BF00196577.
`PMID: 8773261 Review.
`
`44 Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
`Adams KF Jr.
`Am J Health Syst Pharm. 2004 May 1;61 Suppl 2:S4-13. doi: 10.1093/ajhp/61.suppl_2.S4.
`PMID: 15160833 Review.
`
`45 Technology insight: hand-carried ultrasound cardiac assessment--evolution, not revolution.
`Kimura BJ, DeMaria AN.
`Nat Clin Pract Cardiovasc Med. 2005 Apr;2(4):217-23; quiz 224. doi: 10.1038/ncpcardio0154.
`PMID: 16265486 Review.
`
`46 Protective effects of estrogen on the cardiovascular system.
`Mendelsohn ME.
`Am J Cardiol. 2002 Jun 20;89(12A):12E-17E; discussion 17E-18E. doi: 10.1016/s0002-9149(02)02405-0.
`PMID: 12084397 Review.
`
`47 Cardiovascular effects of secondhand smoke: nearly as large as smoking.
`Barnoya J, Glantz SA.
`Circulation. 2005 May 24;111(20):2684-98. doi: 10.1161/CIRCULATIONAHA.104.492215.
`PMID: 15911719 Review.
`
`48 The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
`Hirano K.
`Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):27-36. doi: 10.1161/01.ATV.0000251995.73307.2d. Epub 2006 Nov 9.
`PMID: 17095716 Review.
`
`Liquidia's Exhibit 1117
`Page 6
`
`

`

`49 Cardiovascular effects of ephedra alkaloids: a comprehensive review.
`Andraws R, Chawla P, Brown DL.
`Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. doi: 10.1016/j.pcad.2004.07.006.
`PMID: 15991150 Review.
`
`50 Cardiovascular causes of airway compression.
`Kussman BD, Geva T, McGowan FX.
`Paediatr Anaesth. 2004 Jan;14(1):60-74. doi: 10.1046/j.1460-9592.2003.01192.x.
`PMID: 14717876 Review.
`
`Page 6
`51 Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease.
`Kario K, McEwen BS, Pickering TG.
`Hypertens Res. 2003 May;26(5):355-67. doi: 10.1291/hypres.26.355.
`PMID: 12887126 Review.
`
`52 Establishing a cardiac MRI program: problems, pitfalls, expectations.
`Atalay MK.
`J Am Coll Radiol. 2005 Sep;2(9):740-8. doi: 10.1016/j.jacr.2005.02.002.
`PMID: 17411921 Review.
`
`53 Endoxin:a major factor regulating cardiovascular system.
`Ke YS.
`Acta Pharmacol Sin. 2001 Mar;22(3):201-9.
`PMID: 11742565 Review.
`
`54 Systems biology approaches to metabolic and cardiovascular disorders: network perspectives of cardiovascular
`metabolism.
`Weiss JN, Yang L, Qu Z.
`J Lipid Res. 2006 Nov;47(11):2355-66. doi: 10.1194/jlr.R600023-JLR200. Epub 2006 Aug 31.
`PMID: 16946414 Review.
`
`55 Coxibs and heart disease: what we have learned and what else we need to know.
`Zarraga IG, Schwarz ER.
`J Am Coll Cardiol. 2007 Jan 2;49(1):1-14. doi: 10.1016/j.jacc.2006.10.003. Epub 2006 Dec 13.
`PMID: 17207715 Review.
`
`56 Exercise assessment of transgenic models of human cardiovascular disease.
`Bernstein D.
`Physiol Genomics. 2003 May 13;13(3):217-26. doi: 10.1152/physiolgenomics.00188.2002. Epub 2003 May 13.
`PMID: 12746466 Review.
`
`57 Cardiovascular effects of coffee: is it a risk factor?
`Sudano I, Binggeli C, Spieker L, Lüscher TF, Ruschitzka F, Noll G, Corti R.
`Prog Cardiovasc Nurs. 2005 Spring;20(2):65-9. doi: 10.1111/j.0889-7204.2005.02477.x.
`PMID: 15886549 Review.
`
`58 Cardiovascular manifestations of hypertension in children.
`Finta KM.
`Pediatr Clin North Am. 1993 Feb;40(1):51-9. doi: 10.1016/s0031-3955(16)38480-2.
`PMID: 8417409 Review.
`
`59 The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator.
`Lüscher TF, Noll G.
`Atherosclerosis. 1995 Dec;118 Suppl:S81-90.
`
`Liquidia's Exhibit 1117
`Page 7
`
`

`

`PMID: 8821468 Review.
`
`60 Effects of excess calcium load on the cardiovascular system measured with electron beam tomography in end-stage
`renal disease.
`Raggi P.
`Nephrol Dial Transplant. 2002 Feb;17(2):332-5. doi: 10.1093/ndt/17.2.332.
`PMID: 11812901 Review.
`
`Page 7
`61 Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects.
`Valli G, Giardina EG.
`J Am Coll Cardiol. 2002 Apr 3;39(7):1083-95. doi: 10.1016/s0735-1097(02)01749-7.
`PMID: 11923030 Free article. Review.
`
`62 What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
`Janssens S, Lijnen HR.
`Cardiovasc Res. 2006 Feb 15;69(3):585-94. doi: 10.1016/j.cardiores.2005.12.010. Epub 2006 Jan 19.
`PMID: 16426591 Review.
`
`63 Effect of dark chocolate on arterial function in healthy individuals: cocoa instead of ambrosia?
`Vlachopoulos C, Alexopoulos N, Stefanadis C.
`Curr Hypertens Rep. 2006 Jun;8(3):205-11. doi: 10.1007/s11906-006-0052-5.
`PMID: 17147918 Review.
`
`64
`
`Interfaces of psychopharmacology and cardiology--Part two.
`Risch SC, Groom GP, Janowsky DS.
`J Clin Psychiatry. 1981 Feb;42(2):47-59.
`PMID: 6109718 Review.
`
`65 Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm.
`Raupach T, Schäfer K, Konstantinides S, Andreas S.
`Eur Heart J. 2006 Feb;27(4):386-92. doi: 10.1093/eurheartj/ehi601. Epub 2005 Oct 17.
`PMID: 16230308 Review.
`
`66 Cardiovascular drugs: adenosine role in coronary syndromes and percutaneous coronary interventions.
`Rosales OR, Eades B, Assali AR.
`Catheter Cardiovasc Interv. 2004 Jul;62(3):358-63. doi: 10.1002/ccd.20079.
`PMID: 15224305 Review.
`
`67 Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?
`Corti R, Burnett JC Jr, Rouleau JL, Ruschitzka F, Lüscher TF.
`Circulation. 2001 Oct 9;104(15):1856-62. doi: 10.1161/hc4001.097191.
`PMID: 11591626 Review.
`
`68 The atrial natriuretic peptide: a changing view.
`Rubattu S, Volpe M.
`J Hypertens. 2001 Nov;19(11):1923-31. doi: 10.1097/00004872-200111000-00001.
`PMID: 11677356 Review.
`
`69 A modular numerical model of the cardiovascular system for studying and training in the field of cardiovascular
`physiopathology.
`Ferrari G, De Lazzari C, Mimmo R, Tosti G, Ambrosi D.
`J Biomed Eng. 1992 Mar;14(2):91-107. doi: 10.1016/0141-5425(92)90014-c.
`PMID: 1564928
`
`Liquidia's Exhibit 1117
`Page 8
`
`

`

`70 Cardiovascular effects of the thiazolidinediones.
`Qayyum R, Schulman P.
`Diabetes Metab Res Rev. 2006 Mar-Apr;22(2):88-97. doi: 10.1002/dmrr.596.
`PMID: 16184618 Review.
`
`Page 8
`71 Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms.
`Du XJ, Fang L, Kiriazis H.
`Pharmacol Ther. 2006 Aug;111(2):434-75. doi: 10.1016/j.pharmthera.2005.10.016. Epub 2006 Jan 24.
`PMID: 16439025 Review.
`
`72 Comparative tolerability of contrast media used for coronary interventions.
`Esplugas E, Cequier A, Gomez-Hospital JA, Del Blanco BG, Jara F.
`Drug Saf. 2002;25(15):1079-98. doi: 10.2165/00002018-200225150-00003.
`PMID: 12452733 Review.
`
`73
`
`[Gene therapy in cardiology].
`Jay D.
`Arch Cardiol Mex. 2002 Jan-Mar;72 Suppl 1:S91-4.
`PMID: 12001880 Review. Spanish.
`
`74 Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
`Dilaveris P, Giannopoulos G, Synetos A, Gatzoulis K, Stefanadis C.
`Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):313-8. doi: 10.2174/187152506778520709.
`PMID: 17073608 Review.
`
`75 Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in
`randomized controlled trials?
`Koh KK, Sakuma I.
`Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1171-9. doi: 10.1161/01.ATV.0000131262.98040.65. Epub 2004 May 6.
`PMID: 15130916 Review.
`
`76 Novel NAD(P)H oxidases in the cardiovascular system.
`Griendling KK.
`Heart. 2004 May;90(5):491-3. doi: 10.1136/hrt.2003.029397.
`PMID: 15084538 Free PMC article. Review. No abstract available.
`
`77
`
`78
`
`[Echocardiographic assessment of heart failure].
`Kodama M, Toma Y, Matsuzaki M.
`Nihon Rinsho. 1993 May;51(5):1233-40.
`PMID: 8331791 Review. Japanese.
`
`[Pathomorphologic changes in the sympathetic portion of the autonomic nervous system and cardiovascular pathology].
`Shvalev VN.
`Arkh Patol. 1999 May-Jun;61(3):50-2.
`PMID: 10476350 Review. Russian.
`
`79 Cardiovascular changes in thyroid disorder.
`Gupta R, Varma Y, Yadav BS, Gupta R, Gupta S, Gupta N.
`J Indian Med Assoc. 2006 Oct;104(10):574, 576-8.
`PMID: 17380822 Review.
`
`80 Atlas of pediatric nuclear cardiology: part I.
`Sty JR.
`Clin Nucl Med. 1980 Aug;5(8):373-86. doi: 10.1097/00003072-198008000-00011.
`
`Liquidia's Exhibit 1117
`Page 9
`
`

`

`PMID: 6994977 Review.
`
`Page 9
`81 Effects of cocaine and alcohol alone and in combination on cardiovascular performance in dogs.
`Mehta MC, Jain AC, Billie M.
`Am J Med Sci. 2002 Aug;324(2):76-83. doi: 10.1097/00000441-200208000-00006.
`PMID: 12186111
`
`82 Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-
`year follow-up study.
`Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G, Novo S.
`Stroke. 2006 Feb;37(2):482-6. doi: 10.1161/01.STR.0000198813.56398.14. Epub 2005 Dec 22.
`PMID: 16373649
`
`83 Applications of ultrasound in cardiology and cardiovascular physiology.
`JOYNER CR Jr, REID JM.
`Prog Cardiovasc Dis. 1963 Mar;5:482-97. doi: 10.1016/s0033-0620(63)80011-0.
`PMID: 13965016 No abstract available.
`
`84 Serial analysis of gene expression: technical considerations and applications to cardiovascular biology.
`Patino WD, Mian OY, Hwang PM.
`Circ Res. 2002 Oct 4;91(7):565-9. doi: 10.1161/01.res.0000036018.76903.18.
`PMID: 12364383 Review.
`
`85 Effect of dark chocolate on arterial function in healthy individuals.
`Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C.
`Am J Hypertens. 2005 Jun;18(6):785-91. doi: 10.1016/j.amjhyper.2004.12.008.
`PMID: 15925737 Clinical Trial.
`
`86
`
`[Collaboration between the cardiologist and the occupational health physician needed for formulating the etiological
`diagnosis and the job fitness evaluation].
`Alessio L, Dei Cas L.
`Med Lav. 2004 Mar-Apr;95(2):98-103.
`PMID: 15218740 Review. Italian.
`
`87 Pro-fibrogenic effects of magnesium deficiency in the cardiovascular system.
`Shivakumar K.
`Magnes Res. 2002 Dec;15(3-4):307-15.
`PMID: 12635886 Review.
`
`88 Metformin and vascular protection: a cardiologist's view.
`Libby P.
`Diabetes Metab. 2003 Sep;29(4 Pt 2):6S117-20. doi: 10.1016/s1262-3636(03)72796-7.
`PMID: 14502109 Review.
`
`89
`
`[Diabetes mellitus as a problem of modern cardiology].
`Dzhakhangirov TSh.
`Kardiologiia. 2005;45(10):55-61.
`PMID: 16234772 Review. Russian.
`
`90 Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.
`Lüscher TF, Barton M.
`Circulation. 2000 Nov 7;102(19):2434-40. doi: 10.1161/01.cir.102.19.2434.
`PMID: 11067800
`
`Liquidia's Exhibit 1117
`Page 10
`
`

`

`Page 10
`91 Growth factor signal transduction defects in the cardiovascular system.
`Waltenberger J.
`Cardiovasc Res. 2005 Feb 15;65(3):574-80. doi: 10.1016/j.cardiores.2004.11.001.
`PMID: 15664383 Review.
`
`92 The role of erythropoietin in myocardial protection: potential mechanisms and applications.
`Schwartzenberg S, Ben-Shoshan J, Keren G, George J.
`Expert Rev Cardiovasc Ther. 2006 Jan;4(1):41-50. doi: 10.1586/14779072.4.1.41.
`PMID: 16375627 Review.
`
`93 The relative effects of progesterone and progestins in hormone replacement therapy.
`Rosano GM, Sarais C, Zoncu S, Mercuro G.
`Hum Reprod. 2000 Jun;15 Suppl 1:60-73. doi: 10.1093/humrep/15.suppl_1.60.
`PMID: 10928419 Review.
`
`94 Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
`Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka
`S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y.
`J Am Soc Nephrol. 2002 Jan;13(1):134-141. doi: 10.1681/ASN.V131134.
`PMID: 11752030 Free article.
`
`95 Therapeutic benefits of increasing natriuretic peptide levels.
`Brunner-La Rocca HP, Kiowski W, Ramsay D, Sütsch G.
`Cardiovasc Res. 2001 Aug 15;51(3):510-20. doi: 10.1016/s0008-6363(01)00302-9.
`PMID: 11476741 Free article. Review.
`
`96 Equine cardiovascular medicine: past, present and future.
`Pipers FS.
`Equine Vet J Suppl. 1995 Sep;(19):3-4. doi: 10.1111/j.2042-3306.1995.tb04983.x.
`PMID: 8933063 No abstract available.
`
`97
`
`98
`
`[Can human recombinant erythropoietin (rHuEPO) be considered as cardiological medicine?].
`Ksiazek P, Ksiazek A.
`Przegl Lek. 2005;62 Suppl 2:22-5.
`PMID: 16623113 Review. Polish.
`
`[Perspectives in ultrasonic examinations in cardiology].
`Hůla J.
`Vnitr Lek. 1994 Jul;40(7):451-4.
`PMID: 8073665 Review. Czech.
`
`99 Death by design. Programmed cell death in cardiovascular biology and disease.
`MacLellan WR, Schneider MD.
`Circ Res. 1997 Aug;81(2):137-44. doi: 10.1161/01.res.81.2.137.
`PMID: 9242174 Review.
`
`100 Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a
`population with prevalent metabolic syndrome.
`Onat A, Sari I, Yazici M, Can G, Hergenç G, Avci GS.
`Int J Cardiol. 2006 Mar 22;108(1):89-95. doi: 10.1016/j.ijcard.2005.06.056. Epub 2005 Aug 8.
`PMID: 16085325
`
`Page 11
`
`Liquidia's Exhibit 1117
`Page 11
`
`

`

`101 Cardiovascular examination with 3.0 Tesla magnetic resonance imaging: first 100 cases at Ramathibodi Hospital.
`Rerkpattanapipat P, Siripornpitak S, Pornkul R, Jongjirasiri S, Laothamatas J.
`J Med Assoc Thai. 2006 Sep;89(9):1388-95.
`PMID: 17100374
`
`102 Cardiac gene therapy: therapeutic potential and current progress.
`Kizana E, Alexander IE.
`Curr Gene Ther. 2003 Oct;3(5):418-51. doi: 10.2174/1566523034578249.
`PMID: 14529350 Review.
`
`103 Contrast nephropathy, cardiology and the newer radiocontrast agents.
`Taliercio CP, Burnett JC.
`Int J Cardiol. 1988 May;19(2):145-51. doi: 10.1016/0167-5273(88)90075-7.
`PMID: 3286534 Review. No abstract available.
`
`104 Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study.
`Pitsavos C, Panagiotakos DB, Tzima N, Chrysohoou C, Economou M, Zampelas A, Stefanadis C.
`Am J Clin Nutr. 2005 Sep;82(3):694-9. doi: 10.1093/ajcn.82.3.694.
`PMID: 16155285
`
`105 The performance of information technology in a cardiovascular system.
`Bera LG, Manitiu I.
`Stud Health Technol Inform. 2004;105:222-30.
`PMID: 15718611
`
`106 Highlights of the year in JACC 2004.
`Demaria AN, Ben-Yehuda O, Berman D, Feld GK, Greenberg BH, Knoke JD, Knowlton KU, Lew WY, Narula J, Sahn D, Tsimikas S.
`J Am Coll Cardiol. 2005 Jan 4;45(1):137-53. doi: 10.1016/j.jacc.2004.11.015.
`PMID: 15629388 Review. No abstract available.
`
`107
`
`[Human ecological cardiology].
`Mirrakhimov MM.
`Kardiologiia. 1979 Aug;19(8):44-8.
`PMID: 491358 Russian.
`
`108 Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections.
`Vlachopoulos C, Panagiotakos D, Ioakeimidis N, Dima I, Stefanadis C.
`Am J Clin Nutr. 2005 Jun;81(6):1307-12. doi: 10.1093/ajcn/81.6.1307.
`PMID: 15941880
`
`109 Age Associated Alterations in Structure and Function of the Cardiovascular System.
`Patel MB, Sonnenblick EH.
`Am J Geriatr Cardiol. 1998 Mar;7(2):15-22.
`PMID: 11416448
`
`110 MR blood flow measurement. Clinical application in the heart and circulation.
`Mohiaddin RH, Pennell DJ.
`Cardiol Clin. 1998 May;16(2):161-87. doi: 10.1016/s0733-8651(05)70007-2.
`PMID: 9627755 Review.
`
`Page 12
`111 Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase.
`Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmondson RD, Jones RC, Qiao X, Whitelegge JP, Ping P, Vondriska TM.
`Proteomics. 2005 Aug;5(13):3520-30. doi: 10.1002/pmic.200401308.
`PMID: 16052623
`
`Liquidia's Exhibit 1117
`Page 12
`
`

`

`112 Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in
`postmenopausal women.
`Klein KP, Herrington DM.
`Medscape Womens Health. 2002 Sep-Oct;7(5):2.
`PMID: 12466731 Review. No abstract available.
`
`113 American Heart Association-Bugher Foundation Centers for Molecular Biology in the Cardiovascular System.
`Morgan HE, Paul SR.
`Circulation. 1995 Jan 15;91(2):487-93. doi: 10.1161/01.cir.91.2.487.
`PMID: 7805254
`
`114 High frequency of aspirin resistance in patients with acute coronary syndrome.
`Hobikoglu GF, Norgaz T, Aksu H, Ozer O, Erturk M, Nurkalem Z, Narin A.
`Tohoku J Exp Med. 2005 Sep;207(1):59-64. doi: 10.1620/tjem.207.59.
`PMID: 16082156
`
`115 Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer
`407 and implications for cardiovascular gene therapy.
`March KL, Madison JE, Trapnell BC.
`Hum Gene Ther. 1995 Jan;6(1):41-53. doi: 10.1089/hum.1995.6.1-41.
`PMID: 7703286
`
`116 Abstracts of the Canadian Cardiovascular Congress 2003 held jointly with the XIX InterAmerican Congress of Cardiology
`and the 56th annual meeting of the Canadian Cardiovascular Society. October 24-29, 2003, Toronto, Canada.
`[No authors listed]
`Can J Cardiol. 2003 Oct;19 Suppl A:49A-295A.
`PMID: 14587499 No abstract available.
`
`117
`
`[Gerontological aspects of cardiology].
`Chebotarev DF.
`Kardiologiia. 1976 Mar;16(3):5-11.
`PMID: 1021633 Russian.
`
`118 Methods of local gene delivery to vascular tissues.
`March KL.
`Semin Interv Cardiol. 1996 Sep;1(3):215-23.
`PMID: 9552514 Review.
`
`119 Molecular biology in cardiology: recent developments and opportunities for clinical applications.
`Williams RS.
`Am J Med Sci. 1990 Nov;300(5):304-10. doi: 10.1097/00000441-199011000-00007.
`PMID: 2240019
`
`120 Cardiovascular medicine. Islamic heritage: concepts and contributions.
`Ilyas M.
`J Pak Med Assoc. 1985 Sep;35(9):290-3.
`PMID: 3934418 No abstract available.
`
`Page 13
`121 Canadian Cardiovascular Congress 2001 and 54th annual meeting of the Canadian Cardiovascular Society. October 20-
`24, 2001. Halifax, Nova Scotia, Canada. Abstracts.
`[No authors listed]
`Can J Cardiol. 2001 Sep;17 Suppl C:89C-288C.
`PMID: 11603365 No abstract available.
`
`Liquidia's Exhibit 1117
`Page 13
`
`

`

`122
`
`123
`
`[Abstracts of the 27th Fall Meeting of the German Society of Cardiology and Cardiovascular Research. 16-18 October
`2003, Munster, Germany].
`[No authors listed]
`Z Kardiol. 2003;92 Suppl 2:1-126.
`PMID: 14640139 German. No abstract available.
`
`[Endocrinological aspects of cardiology: the successes and problems].
`Men'shikov VV.
`Kardiologiia. 1979 Mar;19(3):5-10.
`PMID: 34747 Review. Russian. No abstract available.
`
`124 Cystic medial necrosis of the aorta in patients without Marfan's syndrome: surgical outcome and long-term follow-up.
`Marsalese DL, Moodie DS, Lytle BW, Cosgrove DM, Ratliff NB, Goormastic M, Kovacs A.
`J Am Coll Cardiol. 1990 Jul;16(1):68-73. doi: 10.1016/0735-1097(90)90458-2.
`PMID: 2358606 Free article.
`
`125 Perspectives in cardiac ultrasound.
`Roelandt JR, Bruining N, Bom N.
`Przegl Lek. 2002;59(8):557-61.
`PMID: 12638319 Review. No abstract available.
`
`126 Proceedings of a symposium on cardiovascular research: Past triumphs and future prospects. Glasgow, Scotland, 7-8
`October 1994. A festschrift for AF Lever, JJ Brown and JIS Robertson.
`[No authors listed]
`J Hum Hypertens. 1995 Jun;9(6):371-521.
`PMID: 7473512 No abstract available.
`
`127
`
`128
`
`129
`
`130
`
`[Abstracts of the 26th Fall Meeting of the German Society of Cardiology and Cardiovascular Research. 17-19 October
`2002, Magdeburg].
`[No authors listed]
`Z Kardiol. 2002;91 Suppl 5:V1-107.
`PMID: 12462223 German. No abstract available.
`
`[24th Autumn session of the German Society of Cardiology and Cardiovascular Research. 21-23 September 2000,
`Munster. Abstracts].
`[No authors listed]
`Z Kardiol. 2000;89 Suppl 6:1-133.
`PMID: 11028195 German. No abstract available.
`
`[63rd Annual meeting of the German Society of Cardiology and Cardiovascular Research. Mannheim, 3-5 April 1997.
`Abstracts].
`[No authors listed]
`Z Kardiol. 1997;86 Suppl 2:A6-385.
`PMID: 9253426 German. No abstract available.
`
`[62nd Annual meeting of the German Association for Cardiology and Cardiovascular Research. Mannheim, 11-13 April
`1996. Abstracts].
`[No authors listed]
`Z Kardiol. 1996;85 Suppl 2:1-331.
`PMID: 8968421 German. No abstract available.
`
`131
`
`Page 14
`[23rd Autumn session of the German Society of Cardiology and Cardiovascular Research. Nurenberg, 1-2 October 1999.
`Abstracts].
`[No authors listed]
`
`Liquidia's Exhibit 1117
`Page 14
`
`

`

`Z Kardiol. 1999;88 Suppl 2:II1-118.
`PMID: 10549337 German. No abstract available.
`
`13